Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Echoiq Ltd

Healthcare AU EIQ

1.235AUD
0.01(0.82%)

Last update at 2026-06-24T05:25:00Z

Day Range

1.101.25
LowHigh

52 Week Range

0.171.46
LowHigh

Fundamentals

  • Previous Close 1.23
  • Market Cap806.25M
  • Volume3361528
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-15.36100M
  • Revenue TTM0.09M
  • Revenue Per Share TTM-
  • Gross Profit TTM -4.30774M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -13.26251M -5.40915M -8.26581M -6.49060M -3.41217M
Minority interest - - - - -
Net income -13.26251M -5.40915M -8.26581M -5.99204M -2.99425M
Selling general administrative 9.59M 4.23M 4.38M 4.24M 2.40M
Selling and marketing expenses 0.27M 0.01M 0.11M -0.89997M -0.39201M
Gross profit -3.13837M -2.87980M -7.00956M -3.19058M -1.75024M
Reconciled depreciation - 0.60M 0.61M 0.64M 0.27M
Ebit -13.12886M -5.40915M -8.26580M -6.53115M -3.75714M
Ebitda -12.73965M -4.80549M -7.65853M -5.89094M -3.48704M
Depreciation and amortization 0.39M 0.60M 0.61M 0.64M 0.27M
Non operating income net other - - - - -
Operating income -12.99683M -5.92255M -8.26580M -6.53115M -3.75714M
Other operating expenses 13.10M 5.97M 8.37M 6.78M 4.20M
Interest expense - - - 0.00163M 0.00163M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.20M - - 0.00000M 0.00143M
Net interest income - - - - -0.00163M
Extraordinary items - 0.00000M 0.41M 0.50M 0.42M
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.00000M 0.00000M -0.49856M -0.41792M
Total revenue 0.10M 0.04M 0.11M 0.25M 0.44M
Total operating expenses 9.86M 3.04M 1.26M 3.34M 2.01M
Cost of revenue 3.24M 2.92M 7.12M 3.44M 2.19M
Total other income expense net -0.26569M 0.51M -0.00001M 0.04M 0.34M
Discontinued operations - - 0.41M 0.50M 0.42M
Net income from continuing ops - -5.40915M -8.21354M -6.49060M -2.99425M
Net income applicable to common shares -13.26251M -5.40915M -7.85562M -6.17212M -2.99426M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 23.37M 8.26M 10.38M 9.97M 10.74M
Intangible assets 4.69M - 6.37M 7.16M 6.34M
Earning assets - - - - -
Other current assets 11.81M 0.24M 0.00000M 0.50M 0.00089M
Total liab 0.62M 1.49M 2.95M 2.13M 1.42M
Total stockholder equity 22.76M 6.77M 7.44M 7.84M 9.32M
Deferred long term liab - - - - -
Other current liab 0.39M 0.12M 0.01000M 0.55M 0.17M
Common stock 64.62M 41.53M 36.00M 30.40M 26.43M
Capital stock - - 36.00M 30.40M 27.94M
Retained earnings -49.03162M -39.09534M -35.13942M -27.89543M -21.70905M
Other liab - - - - 0.00145M
Good will - - - 0.14M 0.14M
Other assets - - - 0.00040M -
Cash 6.62M 2.12M 3.28M 2.41M 3.81M
Cash and equivalents - - - 2.41M 3.81M
Total current liabilities 0.62M 1.49M 2.95M 2.13M 1.18M
Current deferred revenue - 0.01M 0.01M 0.01M 0.49M
Net debt -6.61770M -2.11733M -3.27640M -2.40691M -3.76821M
Short term debt - - 0.08M 0.04M 0.03M
Short long term debt - - - - -
Short long term debt total - - - - 0.04M
Other stockholder equity - - -0.80569M -2.68500M -6.21672M
Property plant equipment - - 0.03M 0.04M 0.03M
Total current assets 18.65M 2.45M 3.98M 2.76M 4.36M
Long term investments - - 0.00455M 0.00455M 0.00455M
Net tangible assets - - 1.02M 1.05M 3.22M
Short term investments - - - 0.00000M 0.00000M
Net receivables 0.21M 0.10M 0.64M 0.36M 0.55M
Long term debt - - - - -
Inventory - - - - -0.00089M
Accounts payable 0.22M 1.36M 2.85M 1.53M 0.49M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.17M 4.33M 6.58M 5.33M 4.60M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 5.78M 0.00035M 0.00035M -0.00000M
Deferred long term asset charges - - - - -
Non current assets total 4.73M 5.80M 6.41M 7.21M 6.38M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - 0.00000M -0.05981M -0.36733M -1.00256M
Change to liabilities - - 0.05M 0.29M 0.10M
Total cashflows from investing activities -11.55409M - -0.05981M 0.14M -1.00256M
Net borrowings - - - - -0.02147M
Total cash from financing activities 22.56M 2.77M 5.88M 1.55M 2.77M
Change to operating activities - - 0.04M -0.14599M 0.02M
Net income -13.26251M -5.40915M -8.26581M -6.49060M -3.41198M
Change in cash 4.50M -1.15907M 0.87M -1.40513M 0.33M
Begin period cash flow 2.12M 3.28M 2.41M 3.81M 3.48M
End period cash flow 6.62M 2.12M 3.28M 2.41M 3.81M
Total cash from operating activities -6.50891M -3.92420M -4.94029M -2.58480M -1.43126M
Issuance of capital stock - 2.76M 6.07M 1.55M 2.94M
Depreciation 0.58M 0.60M 0.61M 0.64M 0.27M
Other cashflows from investing activities -11.51829M 0.00000M - 0.50M 0.00000M
Dividends paid - - - - 2.61M
Change to inventory - - -0.08762M -0.13995M -0.12825M
Change to account receivables -0.11467M -0.10930M 0.12M -0.15593M -0.38147M
Sale purchase of stock - - -0.18702M -0.16803M -0.15378M
Other cashflows from financing activities - 2.76M 0.19M 0.17M 2.77M
Change to netincome - - 2.50M 2.63M 1.55M
Capital expenditures 0.04M 0.00000M 0.34M 0.37M 1.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.15661M -0.08326M 0.20M -0.01597M -0.25322M
Stock based compensation 6.72M 0.81M 2.38M 2.63M 1.55M
Other non cash items -0.38865M 0.15M 3.56M 4.44M 2.80M
Free cash flow -6.54471M -3.92420M -5.27996M -2.95213M -2.43382M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EIQ
Echoiq Ltd		 0.01 0.82% 1.24 - - 8868.79 46.69 8745.45 -8.2701
PME
Pro Medicus Ltd		 7.88 4.56% 180.81 75.07 96.15 72.79 45.37 72.45 93.64
AYA
ARTRYA Ltd		 0.24 4.65% 5.40 - - 25849.59 8.48 8210.83 0.33
CGS
Cogstate Ltd		 0.01 0.36% 2.77 31.33 25.19 8.54 6.35 5.50 17.11
ONE
Oneview Healthcare Plc		 -0.005 3.12% 0.15 - - 12.46 24.98 7.29 -3.5247

Reports Covered

Stock Research & News

View All

Profile

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company has a research collaboration with Mayo Clinic to evaluate echo IQ's proprietary artificial intelligence platform for cardiac risk stratification in oncology patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.

Echoiq Ltd

66 Clarence Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Andrew Grover Interim MD & Exec. Chairman NA
Jacki McAvenna Chief Financial Officer NA
Mr. Philip Woolff Chief Operating Officer NA
Sean Bryceland Chief Technology Officer NA
Prof. David Playford Chief Medical Officer- Medical Advisory Team NA
Mr. Donald L. Fowler Pres of Echo IQ USA NA
Ms. Jessamyn Sarah Lyons AGIA, B.Com. Joint Company Secreatry NA
Adam Uren Joint Company Sec. NA
Mr. Andrew Grover Interim MD & Executive Chairman NA
Mr. Donald L. Fowler President of Echo IQ USA NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.